BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 29874098)

  • 1. Longitudinal Phenotypes and Mortality in Preserved Ratio Impaired Spirometry in the COPDGene Study.
    Wan ES; Fortis S; Regan EA; Hokanson J; Han MK; Casaburi R; Make BJ; Crapo JD; DeMeo DL; Silverman EK;
    Am J Respir Crit Care Med; 2018 Dec; 198(11):1397-1405. PubMed ID: 29874098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significant Spirometric Transitions and Preserved Ratio Impaired Spirometry Among Ever Smokers.
    Wan ES; Hokanson JE; Regan EA; Young KA; Make BJ; DeMeo DL; Mason SE; San Jose Estepar R; Crapo JD; Silverman EK
    Chest; 2022 Mar; 161(3):651-661. PubMed ID: 34592319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiology, genetics, and subtyping of preserved ratio impaired spirometry (PRISm) in COPDGene.
    Wan ES; Castaldi PJ; Cho MH; Hokanson JE; Regan EA; Make BJ; Beaty TH; Han MK; Curtis JL; Curran-Everett D; Lynch DA; DeMeo DL; Crapo JD; Silverman EK;
    Respir Res; 2014 Aug; 15(1):89. PubMed ID: 25096860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trajectory and mortality of preserved ratio impaired spirometry: the Rotterdam Study.
    Wijnant SRA; De Roos E; Kavousi M; Stricker BH; Terzikhan N; Lahousse L; Brusselle GG
    Eur Respir J; 2020 Jan; 55(1):. PubMed ID: 31601717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low FVC/TLC in Preserved Ratio Impaired Spirometry (PRISm) is associated with features of and progression to obstructive lung disease.
    Fortis S; Comellas A; Kim V; Casaburi R; Hokanson JE; Crapo JD; Silverman EK; Wan ES
    Sci Rep; 2020 Mar; 10(1):5169. PubMed ID: 32198360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 10-Year Follow-Up of Lung Function, Respiratory Symptoms, and Functional Capacity in the COPDGene Study.
    Ragland MF; Strand M; Baraghoshi D; Young KA; Kinney GL; Austin E; Hokanson JE; Regan E; Crapo J; Silverman EK; Make B
    Ann Am Thorac Soc; 2022 Mar; 19(3):381-388. PubMed ID: 34461026
    [No Abstract]   [Full Text] [Related]  

  • 7. Prevalence, risk factors, and clinical implications of preserved ratio impaired spirometry: a UK Biobank cohort analysis.
    Higbee DH; Granell R; Davey Smith G; Dodd JW
    Lancet Respir Med; 2022 Feb; 10(2):149-157. PubMed ID: 34739861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association Between Preserved Ratio Impaired Spirometry and Clinical Outcomes in US Adults.
    Wan ES; Balte P; Schwartz JE; Bhatt SP; Cassano PA; Couper D; Daviglus ML; Dransfield MT; Gharib SA; Jacobs DR; Kalhan R; London SJ; Navas-Acien A; O'Connor GT; Sanders JL; Smith BM; White W; Yende S; Oelsner EC
    JAMA; 2021 Dec; 326(22):2287-2298. PubMed ID: 34905031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imaging Features of Chronic Bronchitis with Preserved Ratio and Impaired Spirometry (PRISm).
    Wei X; Ding Q; Yu N; Mi J; Ren J; Li J; Xu S; Gao Y; Guo Y
    Lung; 2018 Dec; 196(6):649-658. PubMed ID: 30218155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trajectories of Spirometric Patterns, Obstructive and PRISm, in a Population-Based Cohort in Latin America.
    Perez-Padilla R; Montes de Oca M; Thirion-Romero I; Wehrmeister FC; Lopez MV; Valdivia G; Jardim JR; Muino A; B Menezes AM;
    Int J Chron Obstruct Pulmon Dis; 2023; 18():1277-1285. PubMed ID: 37366430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and Characteristics of Individuals with Preserved Ratio Impaired Spirometry (PRISm) and/or Impaired Lung Function in Japan: The OCEAN Study.
    Kaise T; Sakihara E; Tamaki K; Miyata H; Hirahara N; Kirichek O; Tawara R; Akiyama S; Katsumata M; Haruya M; Ishii T; Simard EP; Miller BE; Tal-Singer R
    Int J Chron Obstruct Pulmon Dis; 2021; 16():2665-2675. PubMed ID: 34588775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significant predictors of medically diagnosed chronic obstructive pulmonary disease in patients with preserved ratio impaired spirometry: a 3-year cohort study.
    Park HJ; Byun MK; Rhee CK; Kim K; Kim HJ; Yoo KH
    Respir Res; 2018 Sep; 19(1):185. PubMed ID: 30249256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of gastroesophageal reflux on longitudinal lung function and quantitative computed tomography in the COPDGene cohort.
    Baldomero AK; Wendt CH; Petersen A; Gaeckle NT; Han MK; Kunisaki KM;
    Respir Res; 2020 Aug; 21(1):203. PubMed ID: 32746820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different Risks of Mortality and Longitudinal Transition Trajectories in New Potential Subtypes of the Preserved Ratio Impaired Spirometry: Evidence From the English Longitudinal Study of Aging.
    He D; Sun Y; Gao M; Wu Q; Cheng Z; Li J; Zhou Y; Ying K; Zhu Y
    Front Med (Lausanne); 2021; 8():755855. PubMed ID: 34859011
    [No Abstract]   [Full Text] [Related]  

  • 15. Restrictive Spirometry Pattern, Cardiac Structure and Function, and Incident Heart Failure in African Americans. The Jackson Heart Study.
    Jankowich M; Elston B; Liu Q; Abbasi S; Wu WC; Blackshear C; Godfrey M; Choudhary G
    Ann Am Thorac Soc; 2018 Oct; 15(10):1186-1196. PubMed ID: 30011374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preserved ratio impaired spirometry is associated with small airway dysfunction and reduced total lung capacity.
    Zhao N; Wu F; Peng J; Zheng Y; Tian H; Yang H; Deng Z; Wang Z; Li H; Wen X; Xiao S; Huang P; Dai C; Lu L; Zhou K; Chen S; Zhou Y; Ran P
    Respir Res; 2022 Oct; 23(1):298. PubMed ID: 36316732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prevalence and mortality risks of PRISm and COPD in the United States from NHANES 2007-2012.
    Cadham CJ; Oh H; Han MK; Mannino D; Cook S; Meza R; Levy DT; Sánchez-Romero LM
    Respir Res; 2024 May; 25(1):208. PubMed ID: 38750492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preserved Ratio Impaired Spirometry in a Spirometry Database.
    Schwartz A; Arnold N; Skinner B; Simmering J; Eberlein M; Comellas AP; Fortis S
    Respir Care; 2021 Jan; 66(1):58-65. PubMed ID: 32873751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined Forced Expiratory Volume in 1 Second and Forced Vital Capacity Bronchodilator Response, Exacerbations, and Mortality in Chronic Obstructive Pulmonary Disease.
    Fortis S; Comellas A; Make BJ; Hersh CP; Bodduluri S; Georgopoulos D; Kim V; Criner GJ; Dransfield MT; Bhatt SP;
    Ann Am Thorac Soc; 2019 Jul; 16(7):826-835. PubMed ID: 30908927
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical features and 1-year outcomes of variable obstruction in participants with preserved spirometry: results from the ECOPD study in China.
    Wu F; Li H; Deng Z; Yang H; Zheng Y; Zhao N; Dai C; Peng J; Lu L; Wang Z; Wen X; Xiao S; Zhou K; Wu X; Tang G; Wan Q; Sun R; Cui J; Yang C; Chen S; Huang J; Yu S; Zhou Y; Ran P
    BMJ Open Respir Res; 2024 May; 11(1):. PubMed ID: 38789282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.